Autolus Therapeutics plc (AUTL) Return on equity 2016–2025
Autolus Therapeutics plc (AUTL) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-161.4%FY2025 · since FY2016: -40.9% → -161.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -161.4% | -109.8 pp |
| FY2024 | -51.6% | +135.3 pp |
| FY2023 | -186.9% | — |
| FY2019 | -48.6% | -31.1 pp |
| FY2018 | -17.5% | -3.7 pp |
| FY2017 | -13.8% | +27.1 pp |
| FY2016 | -40.9% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More AUTL financial trends
AUTL RevenueAUTL Net incomeAUTL Net marginAUTL Gross profitAUTL Gross marginAUTL Operating incomeAUTL Operating marginAUTL Operating cash flowAUTL Free cash flowAUTL Capital expendituresAUTL Stock buybacksAUTL Dividends paidAUTL Total assetsAUTL Total liabilitiesAUTL Shareholders’ equityAUTL overview →